You are viewing: Mexico Compounding Pharmacy Market analysis
Part of: Compounding Pharmacy Market (Global)

The Mexico Compounding Pharmacy Market was valued at $56.1 Million in 2025 and projected to reach to $67 Million by 2030, representing a compound annual growth rate of 3.6%. Mexico's compounding pharmacy market is positioned for moderate but consistent growth through 2030, driven by rising healthcare awareness and demand for personalized medication solutions.

Mexico Compounding Pharmacy Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Mexico Compounding Pharmacy Market Trends and Insights

  • Mexico's compounding pharmacy sector is driven by increasing demand for personalized medication solutions and growing healthcare accessibility across both urban and rural regions.
  • The market in Mexico reflects broader Latin American trends toward customized pharmaceutical preparations, supported by regulatory frameworks that recognize compounding as a critical healthcare service. Growth in Mexico's compounding pharmacy market is underpinned by rising chronic disease prevalence, an aging population, and expanding private healthcare infrastructure.
  • Mexico's compounding pharmacies serve diverse patient populations requiring tailored dosages, allergen-free formulations, and pediatric or geriatric adaptations.
  • Between 2025 and 2030, Mexico is expected to see increased investment in compounding facilities and enhanced professional training, positioning the country as a regional hub for specialized pharmaceutical services within Latin America..

Key Market Statistics

  • CAGR (2025-2030) 3.6% CAGR
  • Market Size, 2025 ~USD 56.1 Million
  • Forecast, 2030 ~USD 67 Million
  • Country Mexico

Mexico Compounding Pharmacy Market Overview

Market Size & Growth :

Mexico's compounding pharmacy market is valued at USD 56.1 million in 2025, with projected growth to USD 67.0 million by 2030, reflecting a steady CAGR of 3.6% over the forecast period.

Personalized Medication Demand :

Increasing patient preference for customized pharmaceutical solutions tailored to individual needs is driving adoption of compounding services across Mexico's healthcare system.

Healthcare Accessibility Expansion :

Growing compounding pharmacy presence in both urban centers and rural regions is improving medication accessibility and addressing gaps in traditional pharmaceutical distribution networks.

Below-Global Growth Rate :

Mexico's 3.6% CAGR trails the global market growth of 5.7%, indicating untapped opportunities for market expansion and modernization within the country's compounding sector.

Mexico Compounding Pharmacy Market Dynamics

  • The expansion of compounding services into underserved rural areas presents significant opportunities for market penetration and revenue growth.
  • Healthcare providers increasingly recognize the value of customized formulations in improving patient outcomes and treatment compliance. The market's growth trajectory will be supported by regulatory improvements, increased investment in pharmacy infrastructure, and growing collaboration between compounding pharmacies and healthcare institutions.
  • However, competition from generic pharmaceuticals and varying regulatory frameworks across states may moderate growth rates.
  • Strategic partnerships and technological adoption will be critical for compounding pharmacies to capture emerging opportunities in Mexico's evolving healthcare landscape..

Market Ecosystem

logo-mobile

COMPOUNDING PHARMACY MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
company logo
Provides sterile and non-sterile compounding services, including ready-to-dispense and ready-to-administer personalized medicines for pharmacies, hospitals, and clinics | Its compounding operations support customized strengths, dosage forms, ingredient requirements, and therapies where commercially available medicines may be unsuitable or unavailable. Enables healthcare providers to address patient-specific medication requirements, drug shortages, discontinued products, allergies, and dosage-form limitations while outsourcing complex sterile and non-sterile compounding activities.
company logo
Operates both a 503A compounding pharmacy for patient-specific prescriptions and an FDA-registered 503B outsourcing facility for office-use medications | Its portfolio includes compounded preparations across multiple therapeutic areas and dosage forms, supported by sterile batch testing and cGMP processes at the 503B facility. Expands access to individualized medicines and multiple strengths and dosage forms while enabling healthcare providers to procure larger-scale compounded products from a regulated outsourcing facility.

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

Related Ecosystem

Pharmaceuticals

Top Technologies
  • Bioreactors
  • Analytical Testing
  • Bioanalytical Testing Services
  • Cell Counters
  • Data Management Services
Top Companies
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • SANOFI
  • Pfizer Inc.
  • NOVARTIS

    Key Takeaways

    • Mexico's compounding pharmacy market is valued at USD 56.1 million in 2025 and will reach USD 67.0 million by 2030.
    • Mexico's market is growing at a 3.6% CAGR, reflecting steady demand for personalized pharmaceutical solutions.
    • Mexico's aging population and rising chronic disease burden are primary drivers of compounding pharmacy expansion.
    • Mexico is emerging as a key Latin American market for specialized compounding services and professional pharmacy innovation.

    Compounding Pharmacy Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment HORMONE REPLACEMENT THERAPIES (Therapeutic Application)
    Forecast Period 2025–2030
    Growth Rate CAGR of 5.7% from 2025 to 2030
    Largest Segment PHARMACEUTICAL DOSAGE ALTERATION (Compounding Type)
    Market Size Base Year (Billions) ~USD 14.71 (2025)
    Revenue Forecast (Billions) ~USD 19.41 (2030)
    Segments Covered Product, Compounding Type, Therapeutic Application

    Mexico Compounding Pharmacy Market Report Segmentation

    3 segment dimensions are covered across the global market.

    By Product

    • Nasal Drugs
    • Ophthalmic Drugs
    • Oral Drugs
    • Other Products
    • Parenteral Drugs
    • Rectal Drugs
    • Topical Drugs

    By Compounding Type

    • Currently Unavailable Pharmaceutical Manufacturing
    • Pharmaceutical Dosage Alteration
    • Pharmaceutical Ingredient Alteration

    By Therapeutic Application

    • Dermal Disorders
    • Hormone Replacement Therapies
    • Nutritional Supplements
    • Other Therapeutic Applications
    • Pain Management

    MEXICO: COMPOUNDING PHARMACY MARKET, BY END USER, 2023–2030

    Segment20232024202520262027202820292030CAGR (%)
    ADULTS82.189.795.9100.9104.7107.5110.5113.93.5
    GERIATRIC PATIENTS36.539.64243.945.24646.9482.7
    PEDIATRIC PATIENTS24.627.229.531.43334.335.737.34.8
    TOTAL143.2156.5167.5176.2182.8187.8193.1199.23.5

    Target Audience

    • Compounding Pharmacy Operators : Need market data to expand operations in Mexico, understand growth potential, identify underserved regions, and develop strategic expansion plans for compounding services.
    • Pharmaceutical Manufacturers : Require insights into Mexico's compounding market to assess partnership opportunities, distribution strategies, and demand for customized pharmaceutical formulations.
    • Healthcare Investors & PE Firms : Seek comprehensive market analysis to evaluate investment opportunities in Mexico's compounding pharmacy sector and forecast financial returns through 2030.
    • Healthcare Consultants & Advisors : Need detailed market intelligence to advise clients on market entry, competitive positioning, and strategic opportunities within Mexico's compounding pharmacy industry.
    • Government & Regulatory Bodies : Require market data to inform healthcare policy decisions, assess pharmaceutical accessibility, and develop regulatory frameworks supporting compounding pharmacy growth in Mexico.

    Key Companies in the Mexico Compounding Pharmacy Market

    CompanyHQOwnershipStrongest segments
    BAXTERUnited StatesPublic CompanyMedical Products & Therapies (IV, infusion, parenteral nutrition, renal-related therapies),Healthcare Systems & Technologies (smart beds, monitoring, OR integration, surgical equipment),Pharmaceuticals (generic and specialty injectables, inhaled anesthetics, compounding services),
    FAGRONBelgiumPublic CompanyEssentials (APIs, excipients, bases),Brands (derma, immunology, hair, scar care),Compounding Services,

    BAXTER

    Baxter is a publicly traded American healthcare company founded in 1931 that employs 37,500 people. The company operates as a major medical device and pharmaceutical manufacturer serving global markets.

    FAGRON

    Fagron is a publicly traded Belgian pharmaceutical company founded in 1990 with 4,880 employees. The company focuses on pharmaceutical compounding and specialty pharmacy solutions.

    Reasons to Buy this Report

    • Market Entry Strategy : Gain detailed insights into Mexico's compounding pharmacy landscape to develop informed market entry strategies, identify key growth regions, and understand local competitive dynamics.
    • Investment Decision Support : Access comprehensive market sizing and forecast data to evaluate investment opportunities in Mexico's compounding sector and assess long-term revenue potential through 2030.
    • Competitive Positioning : Understand market drivers, healthcare accessibility trends, and personalized medication demand to position your compounding pharmacy services competitively within Mexico's market.
    • Regulatory & Operational Insights : Identify regional variations, healthcare infrastructure gaps, and regulatory considerations specific to Mexico to optimize operational planning and compliance strategies.
    • Growth Opportunity Identification : Discover untapped segments in urban and rural markets where compounding pharmacy services can address healthcare gaps and capitalize on below-global growth rate potential.

    Frequently asked questions

    What is the current size of Mexico's compounding pharmacy market?

    Mexico's compounding pharmacy market is estimated at USD 56.1 million in 2025.

    What is the projected market size for Mexico's compounding pharmacy sector by 2030?

    Mexico's compounding pharmacy market is forecast to reach USD 67.0 million by 2030.

    What is the growth rate of Mexico's compounding pharmacy market?

    Mexico's compounding pharmacy market is expected to grow at a CAGR of 3.6% from 2025 to 2030.

    What factors are driving growth in Mexico's compounding pharmacy market?

    Key drivers in Mexico include rising chronic disease prevalence, an aging population, increased demand for personalized medications, and expanding private healthcare infrastructure.

    How does Mexico's compounding pharmacy market compare to the global market?

    Mexico's 3.6% CAGR is lower than the global 5.7% CAGR, reflecting regional market maturity and regulatory differences within Latin America.

    RESEARCH METHODOLOGY

    This study involved four major activities to estimate the current size of the compounding pharmacy market. We conducted exhaustive secondary research to gather information on the market, its peer markets, and its parent market. The team then validated these findings, assumptions, and sizing with industry experts across the value chain through primary research. We used both top-down and bottom-up approaches to estimate total market size. We then used data triangulation to estimate market size by segment and subsegment.

    Secondary Research

    Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the compounding pharmacy market. The secondary sources used for this study include US Food and Drug Administration (FDA), American Pharmacists Association (APhA), International Academy of Compounding Pharmacists (IACP), National Community Pharmacists Association (NCPA), Parenteral Drug Association (PDA), American Society of Health-System Pharmacists (ASHP), Pharmacy Compounding Accreditation Board (PCAB), European Directorate for the Quality of Medicines & HealthCare (EDQM), European Medicines Agency (EMA), International Pharmaceutical Federation (FIP), Journal of Compounding & Specialty Pharmacy (JCSP), National Center for Biotechnology Information (NCBI), Pharmaceutical Research and Manufacturers of America (PhRMA), Pharma & Biopharma Outsourcing Association (PBOA), and World Journal of Pharmaceutical Research (WJPR). Secondary sources also include corporate and regulatory filings, such as annual reports, SEC filings, investor presentations, and financial statements; business magazines & research journals; press releases; trade, business, and professional associations; and MarketsandMarkets Analysis. These sources were also used to obtain key information on major players, market classification, and segmentation based on industry trends, regional/country-level markets, market developments, and technology perspectives.

    Primary Research

    We conducted in-depth interviews with primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among others, to obtain and verify critical qualitative and quantitative information and assess market prospects. We interviewed primary sources from both the supply and demand sides of the market to gather qualitative and quantitative data. The following is a breakdown of the primary respondents:

    Compounding Pharmacy Market Size, and Share

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    We estimated the global size of the compounding pharmacy market using multiple approaches. We used a detailed market estimation approach to estimate and validate the market value and other dependent submarkets. We also used these methods extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following.

    Compounding Pharmacy Market: Top-Down and Bottom-Up Approach

    Compounding Pharmacy Market Top Down and Bottom Up Approach

    Data Triangulation

    After estimating the market size using the process described above, we divided the total market into several segments and subsegments. To complete the overall market analysis and obtain precise statistics for all segments and subsegments, we used data triangulation and market breakdown methods where applicable. We triangulated the data by examining factors and trends from both the demand and supply sides.

    Market Definition

    A compounding pharmacy is a specialized practice in which a licensed pharmacist combines, mixes, or alters raw drug ingredients to formulate customized medications tailored to individual patients' unique health needs. This process allows pharmacists to create pharmaceutical products in various forms, such as liquids, creams, gels, or capsules, and can be vital for patients with specific allergies, intolerances, or those needing dosages not commercially available. Compounding pharmacists often work closely with healthcare providers to develop formulas that address particular medical conditions, ensuring that each preparation is safe, effective, and personalized to optimize patient care. Additionally, compounding pharmacies adhere to stringent regulatory standards to maintain the integrity and quality of the medications they produce.

    Key Stakeholders

    • Pharmaceutical & Biotechnology Companies
    • Compounding Pharmacies
    • Research & Consulting Firms
    • Academic Medical Centers
    • Government Regulatory & Research Organizations
    • Quality Assurance & Accreditation Bodies
    • Clinical Research Institutes

    Report Objectives

    • To define, describe, and forecast the compounding pharmacy market based on product, compounding type, therapeutic application, sterility, end user, and region
    • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall compounding pharmacy market
    • To analyze opportunities for stakeholders and provide details of the competitive landscape for market leaders
    • To forecast the size of the market segments with respect to five regions: North America (US and Canada), Europe (Germany, France, the UK, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific), Latin America (Brazil, Mexico, Argentina, and the Rest of Latin America), and the Middle East & Africa (GCC Countries and the Rest of Middle East & Africa)
    • To profile the key players and analyze their market share and core competencies
    • To analyze competitive developments, such as product launches, partnerships, agreements, collaborations, and expansions
    • To benchmark players within the market using the proprietary “Company Evaluation Matrix” framework, which analyzes market players on various parameters within the broad categories of business and product excellence strategy

    Available customizations:

    With the given market data, MarketsandMarkets offers customization as per the company’s specific needs. The following options are available for the report:

    Geographical Analysis

    • A further breakdown of the Rest of Asia Pacific compounding pharmacy market into countries
    • A further breakdown of the Rest of Europe compounding pharmacy market into countries
    • A further breakdown of the Rest of Latin America compounding pharmacy market into countries

    Company Information

    • Detailed analysis and profiling of additional market players (up to five).
     

     

    Get the Full Compounding Pharmacy Market Report

    Full forecast, segment splits, and company analysis for all Compounding Pharmacy Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status